Sean Harrell, MD
Interventional Cardiology · Augusta, GANPI 1528418563
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (50.9%), travel and lodging and grants — rather than concentrated in one kind of arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 23.2%. 2025 is the largest year on record at $3,474, more than ten times the $11 reported in 2019.
Across 154 payments — averaging $67.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$2K
- Medtronic$2K
- Boston Scientific$2K
- Inari Medical, Inc.$911
- Abiomed$671
- Abbott$488
- plus $2K from 18 others
What the payments were for
- Grants$1,42114%
- Travel & lodging$3,16231%
- Food & beverage$5,26651%
- Education$5005%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 8 | $2,401 |
| Medtronic(2 entities) | 31 | $2,151 |
| Boston Scientific | 6 | $1,747 |
| Inari Medical, Inc. | 29 | $911 |
| Abiomed | 15 | $671 |
| Abbott | 6 | $488 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 12 | $330 |
| Asahi Intecc USA, Inc. | 7 | $234 |
| Stryker | 5 | $219 |
| Novartis | 7 | $154 |
| Shockwave Medical, Inc | 3 | $151 |
| AstraZeneca | 3 | $131 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $123 |
| Biosense Webster, Inc. | 1 | $109 |
| W. L. Gore & Associates, Inc. | 1 | $98 |
| Recor Medical Inc | 3 | $94 |
| Johnson & Johnson | 6 | $86 |
| E.r. Squibb & Sons, L.L.C. | 2 | $60 |
| Pfizer | 3 | $58 |
| Actelion Pharmaceuticals US, Inc. | 1 | $42 |
| Terumo Medical Corporation | 1 | $41 |
| Philips North America LLC | 1 | $20 |
| Amgen | 1 | $17 |
| Getinge USA Sales, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$2,249
- COREVALVE EVOLUT R$1,109
- FLOWTRIEVER CATHETER, S$689
- CT THROMBECTOMY SYSTEM KIT$476
- Impella$213
- Ensite Cardiac Mapping System$211
- MitraClip$184
- FlowTriever$126
- ARCALYST$123
- NA$109
- LifeVest$102
How this compares
$10,349 in reported general payments places this provider in the 60th percentile of 218 interventional cardiology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 151 | $2,060 |
| Atorvastatin Calcium | 18 | $234 |
| Spironolactone | 12 | $12 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Augusta
- Charlene RohmAugusta$67K
- Musa SharkawiAugusta$30K
- Vishal AroraAugusta$22K
- William NicholsonAtlanta$1000K
- David KandzariAtlanta$982K
- Pradeep YadavAtlanta$656K
- Salvatore ManninoMarietta$275K
- Megan CoylewrightCalhoun$271K
- Paul GuichardMarietta$260K
- Adam GreenbaumAtlanta$238K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.